Issues: Vax Specific

Anthrax

Hepatitis B

Hib 

HPV

Influenza

Lyme Disease
Meningococcal

MMR    

Pneumococcal    

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation 

New Vax Status

Thimerosal

Independent Vax  Safety Board

 

Vaccine Info

2014 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links
 

Search
 

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy
 

 

Institute for Vaccine Safety

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street

Room W5041

Baltimore, MD 21205

www.vaccinesafety.edu

 

 

 

Components of
Hib & Hepatitis B Vaccine

Excipients Table
Allergens Table
Components Table
 

Indication

For active immunization of infants 6 weeks to 15 months of age born of HBsAg-negative mothers who need protection against both Hib and Hepatitis B

Proprietary Name

Comvax (combination of Pedvax HIB and Recombivax HIB vaccines)

Manufacturer

Merck

Viability

Inactivated

Microorganism

H. influenzae type b, Virus family Hepadnaviridae

Dose

0.5 mL

Route

Intramuscular

Dose form

Suspension

Appearance

Aluminum Hydroxide, ≤0.625 mg

Concentration (per 0.5 mL)

Hib polysaccharide, 7.5 mcg

Hepatitis B surface antigen, 5 mcg

Preservatives

None

Adjuvant

Neisseria meningitides OMP, 125mcg

Aluminum hydroxide, 225mcg

Excipients

Sodium borate decahydrate, 35mcg

Yeast protein, ≤1%

Formaldehyde, ≤0.0004%

Allergens

None

Media

Hib: Complex fermentation media; Hepatitis B: S. cerevisiae

Packaging

Box of 10 single-dose vials

Routine storage

2 to 8 C (36-46 F)

Do Not Freeze

updated July 2005

This page was last updated on February 12, 2014

2014 Institute for Vaccine Safety